The earlier cancer is found, the higher the chance everyone wins: likely better outcomes for those finding it and greater peace of mind for those without it. Offering Galleri®, a multi-cancer early detection test, was found to encourage employees to join, stay, and understand they’re part of a workplace that truly cares.1
The Galleri test is a groundbreaking and potentially life-changing advancement in cancer detection for adults with an elevated risk for cancer, such as those aged 50 or older.
With the Galleri test, employees could receive the benefits of early detection of multiple cancers through a simple blood draw.
50+ cancer types detected
including cancers employees aren’t routinely screened for today9,10
0.5% false-positive rate
to help minimize unnecessary medical procedures9
in predicting the location of the cancer, directing diagnostic workup9
Please check your inbox. You must confirm your subscription to receive emails for the Galleri test.
Important safety information
The Galleri test is recommended for use in adults with an elevated risk for cancer, such as those aged 50 or older. The Galleri test does not detect all cancers and should be used in addition to routine cancer screening tests recommended by a healthcare provider. Galleri is intended to detect cancer signals and predict where in the body the cancer signal is located. Results should be interpreted by a healthcare provider in the context of medical history, clinical signs and symptoms. A test result of“Cancer Signal Not Detected” does not rule out cancer. A test result of“Cancer Signal Detected” requires confirmatory diagnostic evaluation by medically established procedures (e.g. imaging) to confirm cancer. If cancer is not confirmed with further testing, it could mean that cancer is not present or testing was insufficient to detect cancer, including due to the cancer being located in a different part of the body. False-positive (a cancer signal detected when cancer is not present) and false-negative (a cancer signal not detected when cancer is present) test results do occur. Rx only.
Laboratory / test information
GRAIL’s clinical laboratory is certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA) and accredited by the College of American Pathologists (CAP). The Galleri test was developed, and its performance characteristics were determined by GRAIL. The Galleri test has not been cleared or approved by the Food and Drug Administration. GRAIL’s clinical laboratory is regulated under CLIA to perform high-complexity testing. The Galleri test is intended for clinical purposes.